My Size (MYSZ) AI Stock Analysis

• Market Cap: $3.79M
• Dividend Yield: N/A
• Average Volume (3M): 85.80K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.22
• Revenue Growth: -27.08%
• EPS Growth: 86.85%
• Country: US
• Employees: 13
• Sector: Technology
• Sector Strength: 91
• Industry: Software - Application
• EPS (TTM): -0.51
• Shares Outstanding: 3,103,076
• 10 Day Avg. Volume: 58,726
• 30 Day Avg. Volume: 85,796
• PEG Ratio: -0.02
• Price to Book (P/B): 0.43
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -1.30
• Enterprise Value/Market Cap: 0.10
• Enterprise Value/Revenue: 0.01
• Enterprise Value/Gross Profit: 0.15
• Enterprise Value/Ebitda: -0.03
• 1Y Price Target: $1.50
• Price Target Upside: 20.97% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 54 Neutral
• Price Target: $1.50 ▲(20.97%Upside)

The overall stock score reflects the company's strategic acquisition and revenue growth potential, which are positive factors. However, persistent unprofitability and cash flow challenges weigh heavily on valuation and financial stability. Technical indicators show mixed signals, with no strong trend.

Positive Factors

Market Adoption

My Size's unique sizing software, not reliant on privacy damaging cameras, should continue to see greater market exposure.

Operating Efficiency

The sequential improvement in gross margin to 49.7%, up from March's 40.1%, embodies the efficiency gains My Size has fashioned in Orgad's operation.

Revenue Growth

Sequential gain in SaaS revenue to $172,000, up from 2Q24's $163,000, signaling continued interest in My Size solutions.

Negative Factors

Industry Challenges

The software fitting business is a struggle for all participants across the industry primarily on account of retailers' skimpy margins and reluctance to make performance enhancing investment.

Investment Risks

Risks associated with a My Size investment include future dilution while others are latent in the marketing, sale, and adoption of MySizeID.

Revenue Decline

Sales of $1.8M, down 7% sequentially from June's $2.0M, the second consecutive sequential decline, and down 14% year over year from $2.2M.

My Size Business Overview & Revenue Model

Company Description

My Size, Inc. (MYSZ) is a technology company specializing in measurement solutions for a variety of industries. The company's core products include applications that provide accurate size measurements for apparel, shipping, and others. My Size leverages proprietary algorithms and technology to help businesses and consumers optimize their operations through precise measurement tools.

How the Company Makes Money

My Size generates revenue through the sale of its measurement technology solutions to businesses and consumers. The company offers its products as Software-as-a-Service (SaaS), where clients subscribe to use the technology for a fee. Key revenue streams include subscription fees for its applications, partnerships with retail businesses to integrate My Size's measurement technology into their systems, and licensing agreements with other companies seeking to utilize My Size's algorithms and technology. Significant partnerships with major retailers and e-commerce platforms enhance its market reach and contribute to its earnings.

My Size Financial Statement Overview

Summary

Despite strong revenue growth, the company remains unprofitable with ongoing net losses and negative cash flows, indicating challenges in achieving profitability. The balance sheet shows low leverage but cash flow issues highlight the need for better operational efficiency.

Income Statement

The company has shown significant revenue growth, increasing from $63,000 in 2019 to $8,257,000 in 2024. However, despite the revenue growth, the company remains unprofitable with a net loss of $3,995,000 in 2024. Gross profit margin improved to 40.24% in 2024, but the persistent net losses and negative EBIT and EBITDA margins highlight ongoing challenges in achieving profitability.

Balance Sheet

The balance sheet shows a strong equity position with equity increasing to $6,909,000 in 2024. The debt-to-equity ratio is low at 0.04, indicating minimal leverage. However, the company has been burning cash with significant net losses, which could pressure its cash reserves over time.

Cash Flow

The company has consistently negative operating cash flows, with a free cash flow of -$3,099,000 in 2024, indicating reliance on external financing. Although there has been some improvement in free cash flow, the negative operating cash flow to net income ratio suggests operational inefficiencies.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	8.26M	7.00M	4.46M	131.00K	142.00K
Gross Profit	3.32M	2.73M	634.00K	131.00K	140.00K
EBITDA	-3.60M	-6.33M	-8.09M	-10.44M	-6.07M
Net Income	-4.00M	-6.38M	-8.31M	-10.52M	-6.17M
Balance Sheet
Total Assets	10.06M	8.99M	9.73M	12.56M	3.57M
Cash, Cash Equivalents and Short-Term Investments	4.88M	2.19M	2.10M	10.67M	1.69M
Total Debt	276.00K	694.00K	998.00K	611.00K	708.00K
Total Liabilities	3.15M	4.26M	5.19M	1.70M	1.49M
Stockholders Equity	6.91M	4.74M	4.54M	10.86M	2.08M
Cash Flow
Free Cash Flow	-3.10M	-6.11M	-7.32M	-7.32M	-5.72M
Operating Cash Flow	-3.09M	-6.11M	-7.29M	-7.30M	-5.68M
Investing Cash Flow	53.00K	-7.00K	-993.00K	161.00K	-211.00K
Financing Cash Flow	5.59M	6.13M	-67.00K	16.29M	6.09M

My Size Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.24
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MYSZ, the sentiment is Negative. The current price of 1.24 is above the 20-day moving average (MA) of 1.23, above the 50-day MA of 1.24, and below the 200-day MA of 1.64, indicating a neutral trend. The MACD of 0.02 indicates Negative momentum. The RSI at 49.15 is Neutral, neither overbought nor oversold. The STOCH value of 27.80 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MYSZ.

My Size Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	63 Neutral	$33.80B	5.84	-11.67%	1.84%	5.28%	-18.34%
MYSZ	54 Neutral	$3.79M	―	-82.58%	―	-27.08%	86.85%
IDAI	53 Neutral	$7.75M	―	-369.03%	―	-34.68%	-265.79%
SOPA	47 Neutral	$6.21M	―	-528.72%	―	-15.60%	64.21%
OLB	40 Underperform	$4.89M	―	-148.68%	―	-57.50%	65.30%

My Size Corporate Events

My Size Adjusts Stock Options Exercise Price

On June 4, 2025, My Size, Inc. adjusted the exercise price of stock options for certain employees, officers, and directors, lowering it to $1.28 per share, aligning with the closing price on that date. This adjustment affected options for 13,926 shares, including those held by key executives such as CEO Ronen Luzon and former CFO Or Kles. Additionally, the company accelerated the vesting of 18,750 restricted shares for Mr. Kles, recognizing his service, making them fully vested as of his termination on March 31, 2025.

The most recent analyst rating on (MYSZ) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on My Size stock, see the MYSZ Stock Forecast page.

My Size Completes Key Acquisition of Percentil Assets

On May 9, 2025, MySize, Inc., through its wholly-owned subsidiary New Percentil, S.L., acquired key assets of Percentil, a managed marketplace for second-hand fashion, following the insolvency proceedings of its former owner, Casi Nuevo. The acquisition, valued at approximately €610,000, includes Percentil’s warehouse infrastructure, AI-powered pricing engine, and 17 employees, including the former CEO and CMO. This strategic move aligns with MySize’s shift towards a premium re-commerce experience and supports its entry into the circular economy, leveraging Percentil’s platform to offer a B2B resale solution. The acquisition is expected to increase MySize’s total revenue by 25% in the second half of 2025 and positions the company to benefit from upcoming EU regulations on sustainable fashion.

The most recent analyst rating on (MYSZ) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on My Size stock, see the MYSZ Stock Forecast page.